NCT07525518
Okami Medical ALPHA Registry
Enrolling by Invitation
Not specifiedAges 18+ObservationalOkami Medical, Inc.
~500 participants
Updated 2026-07-21 on ClinicalTrials.gov
What's tested:LOBO Vascular Occlusion System
At a glance
Recruiting sites
0 of 4 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Safety Endpoint
Measured over 30 days post-index procedure
+1 more outcome measured
Conditions
Where it's being run
4 sites across 3 statesNorth Carolina2
Colorado1
Massachusetts1
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
The patient or their legally authorized representative is willing and able to provide informed consent per local requirements
Has or will receive treatment with an eligible Okami Medical device
Age ≥ 18 years
Exclusion
Is or will be inaccessible for registry follow-up
Current or planned participation in a drug or device study that would interfere with participation in this registry or confound the results of this registry in the opinion of the investigator
What this trial measures
- Safety Endpoint30 days post-index procedure
Incidence of device-related serious adverse events during the index procedure
- Effectiveness EndpointDuring index procedure
Technical success of the LOBO Vascular Occlusion System defined as occlusion of the intended target(s) with the LOBO occluder, assessed by angiography